Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma

Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma

Effective treatment options for peritoneal surface malignancies (PSMs) are scarce. Oncolytic virotherapy with recombinant vaccinia viruses might constitute a novel treatment option for PSM. We aimed to identify the most effective oncolytic vaccinia virus strain in two murine mesothelioma cell lines...

Full description

Bibliographic Details
Main Authors: Can Yurttas, Julia Beil, Susanne Berchtold, Irina Smirnow, Linus D. Kloker, Bence Sipos, Markus W. Löffler, Alfred Königsrainer, André L. Mihaljevic, Ulrich M. Lauer, Karolin Thiel
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
immunovirotherapy
oncolytic virotherapy
peritoneal carcinomatosis
intraperitoneal therapy
syngeneic murine tumor model
Online Access:https://www.mdpi.com/2072-6694/16/2/368

Internet

https://www.mdpi.com/2072-6694/16/2/368

Similar Items